H Taniguchi Selected Research

H Taniguchi Research Topics

Disease

22	Neoplasms (Cancer) 07/2020 - 03/2000
8	Stomach Neoplasms (Stomach Cancer) 02/2015 - 11/2000
7	Neoplasm Metastasis (Metastasis) 07/2020 - 04/2000
5	Infections 08/2015 - 08/2001
5	Breast Neoplasms (Breast Cancer) 12/2010 - 08/2000
4	Disease Progression 01/2018 - 12/2001
4	Idiopathic Pulmonary Fibrosis 11/2010 - 11/2000
4	Inflammation (Inflammations) 11/2001 - 11/2000
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2018
3	Asthma (Bronchial Asthma) 02/2012 - 11/2001
3	Hepatocellular Carcinoma (Hepatoma) 11/2002 - 03/2001
3	Chlamydophila Infections 11/2001 - 09/2001
3	Eosinophilia 08/2001 - 11/2000
2	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 01/2016
2	Carcinoma (Carcinomatosis) 10/2018 - 07/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2017 - 10/2015
2	Lymphopenia (Lymphocytopenia) 11/2017 - 10/2015
2	Pain (Aches) 04/2016 - 10/2000
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2013 - 11/2011
2	Fibrosis (Cirrhosis) 12/2007 - 01/2000
2	Colonic Neoplasms (Colon Cancer) 10/2007 - 04/2000
2	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2005 - 11/2000
2	Thrombosis (Thrombus) 12/2004 - 03/2001
2	Type 2 Diabetes Mellitus (MODY) 01/2004 - 08/2001
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2004 - 06/2000
2	Paragonimiasis 12/2001 - 01/2001
2	Empyema 08/2001 - 01/2001
2	Acute Liver Failure (Fulminant Hepatic Failure) 06/2001 - 11/2000
2	Body Weight (Weight, Body) 04/2001 - 10/2000
2	Tuberculosis (Tuberculoses) 01/2001 - 09/2000
2	Lymphatic Metastasis 11/2000 - 03/2000
1	Metabolic Bone Diseases (Osteopenia) 07/2020
1	Microsatellite Instability 01/2020
1	Fatigue 01/2018
1	Adenocarcinoma 01/2018
1	Sarcopenia 03/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Encephalitis (Encephalitis, Rasmussen) 08/2015

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 02/2015 - 09/2000
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2010 - 03/2001
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
3	Indicators and Reagents (Reagents)IBA 11/2010 - 09/2000
3	Carcinoembryonic AntigenIBA 12/2007 - 01/2001
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2005 - 09/2000
3	ImmunosorbentsIBA 10/2002 - 11/2000
3	InterleukinsIBA 12/2001 - 11/2000
3	Pamidronate (Aredia)FDA LinkGeneric 11/2001 - 08/2000
3	Interleukin-5 (Interleukin 5)IBA 08/2001 - 11/2000
2	AndrogensIBA 07/2020 - 01/2016
2	Bendamustine Hydrochloride FDA Link 11/2017 - 10/2015
2	Small Interfering RNA (siRNA)IBA 02/2015 - 10/2007
2	montelukast (Singulair)FDA Link 02/2012 - 08/2002
2	Peptides (Polypeptides)IBA 04/2007 - 11/2000
2	Prednisolone (Predate)FDA LinkGeneric 03/2005 - 08/2001
2	AntigensIBA 12/2001 - 01/2001
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2001 - 11/2001
2	FadrozoleIBA 11/2001 - 08/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2001 - 09/2000
2	Tamoxifen FDA LinkGeneric 11/2001 - 08/2000
2	doxifluridineIBA 11/2001 - 08/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2001 - 11/2000
1	YM 529IBA 07/2020
1	Denosumab FDA Link 07/2020
1	Hormones (Hormone)IBA 07/2020
1	Retinoblastoma ProteinIBA 07/2020
1	Positive Regulatory Domain I-Binding Factor 1IBA 07/2020
1	MineralsIBA 07/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	entrectinibIBA 01/2020
1	larotrectinibIBA 01/2020
1	TropomyosinIBA 01/2020
1	PlatinumIBA 10/2018
1	nintedanibIBA 01/2018
1	eribulin FDA Link 01/2018
1	Triglycerides (Triacylglycerol)IBA 03/2017
1	Rituximab (Mabthera)FDA Link 09/2016
1	Analgesics (Analgesic Drugs)IBA 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2016
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2016
1	Explosive Agents (Explosives)IBA 12/2015
1	Untranslated Regions (Untranslated Region)IBA 12/2015

Therapy/Procedure

18	Therapeutics 01/2018 - 04/2000
7	Drug Therapy (Chemotherapy) 10/2018 - 04/2000
4	Transplantation 03/2017 - 05/2014
4	Gastrectomy 07/2010 - 03/2000
3	Neoadjuvant Therapy 11/2001 - 04/2000
2	Combination Drug Therapy (Combination Chemotherapy) 10/2018 - 11/2001
2	Radiotherapy 01/2018 - 03/2000
2	Mechanical Ventilators (Ventilator) 11/2011 - 10/2000
2	Autologous Blood Transfusion 09/2001 - 05/2001
2	Liver Transplantation 08/2001 - 11/2000
1	Subcutaneous Injections 07/2020
1	Immunotherapy 01/2020
1	Kidney Transplantation 03/2017
1	Hematopoietic Stem Cell Transplantation 08/2015